{"url_path":"/sec/cpix/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1087294/0001087294-26-000049-index.html","accession_number":"0001087294-26-000049","cik":"0001087294","ticker":"CPIX","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1087294/0001087294-26-000049-index.html","primary_entity_key":"0001087294","primary_entity_name":"CUMBERLAND PHARMACEUTICALS INC"},"word_count":157,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds\n\nPurchases of Equity Securities\n\nWe currently have a share repurchase program to purchase up to $10 million of our common stock pursuant to Rule 10b-18 of the Exchange Act. In January 2019, our Board of Directors established the current $10 million repurchase program to replace the prior authorizations for repurchases of our outstanding common stock.\n\nThe following table summarizes the activity, by month, during the three months ended March 31, 2026:\n\nPeriod\nTotal Number of\n\nShares (or Units)\n\nPurchased\n\nAverage\n\nPrice Paid\n\nper Share\n\n(or Unit)\n\nTotal Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs\nMaximum number (or Approximate Dollar Value) of Shares (or Units) that May be Purchased Under the Publicly Announced Plans or Programs\n\nJanuary————\n\nFebruary————\n\nMarch20,245\n(1)\n$3.0120,245$61,000.99\n\nTotal20,245\n\n(1) 20,245 shares were repurchased directly in private purchases at the then-current fair market value of common stock."}